Who
Deborah J. Andrews
Chief Financial Officer & EVP
Company insider
Files Form 4 as: Chief Financial Officer & EVP, STAAR Surgical; Director, Lineage Cell Therapeutics.
In numbers
- Trades disclosed
- 171
- Buys
- 5
- Sells
- 30
- Bought
- $28K
- Sold
- $6.9M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 10 Feb 2006
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —5,233 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code F | $70K2,662 at $26.18 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —4,975 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —4,975 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —8,952 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —29,159 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —5,233 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —8,952 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —29,159 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —5,233 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —5,233 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code F | $70K2,662 at $26.18 | filing |
| 31 Jul 2026filed 4 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —20,787 | filing |
| 31 Jul 2026filed 4 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —20,787 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code F | $258K10,576 at $24.36 | filing |
| 31 Jul 2026filed 4 Aug 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —20,787 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —20,787 | filing |
| 31 Jul 2026filed 4 Aug 2026 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code F | $258K10,576 at $24.36 | filing |
| 1 Jul 2026filed 2 Jul 2026 | LCTX Lineage Cell Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | LCTX Lineage Cell Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
News
Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Shares Down 1.2% – What's Next?LCTX · dailypolitical.com · 17 Oct 2026Wall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to BuySTAA · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Deborah J. Andrews; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.